India has decided to liberate foreign direct investment (FDI) in the medical devices sector from the conditions imposed on its pharmaceutical cousins. This begs the question : to what end? To recap, from January 21, FDI in medical devices will qualify for automatic approval of up to 100 per cent. Notably, this is irrespective of … Continue reading Will India’s new #FDI policy in #MedTech have the intended effect?
Stop tinkering with FDI norms : my column in the Indian Express
Today's edition of the Indian Express has an edit piece that I have authored on why the government should stop repeatedly tinkering with India's foreign direct investment (FDI) policy for pharmaceuticals. In this piece I have argued that there is no connection between the availability of essential medicines and the FDI policy and that this … Continue reading Stop tinkering with FDI norms : my column in the Indian Express
FDI in pharma : another punch
The issue of controlling foreign direct investment (FDI) in the Indian pharmaceutical sector continues to make headlines with various arms of the government putting forth their own formulas to tame the grasping foreign hand. The Indian Express reports that the ministry of commerce under Anand Sharma would like all FDI proposals - including where foreign … Continue reading FDI in pharma : another punch
FDI in pharma : India’s quick fix
India seems set to reverse a ten year-old policy governing foreign direct investment (FDI) in pharmaceuticals. If Prime Minister Manmohan Singh gives his nod to the recommendations of an inter-ministerial group then automatic approval for FDI in Indian drug companies will be capped at 49 per cent. Beyond this limit, a foreign investor will have … Continue reading FDI in pharma : India’s quick fix